PhenUtest Diagnostics Ltd echoes British In Vitro Diagnostics Association (BIVDA)’s statement that “diagnostics can save lives now and in the future, by preventing unnecessary antibiotic prescriptions, which slows the impact of AMR”. PhenUtest is excited to be developing a revolutionary Urinary Tract Infection (UTI) diagnostic system that puts this sentiment at the heart of its technology. The PhenUtest system will diagnose a UTI, the causative pathogen and provide antimicrobial susceptibility test results within 60 minutes. PhenUtest's ambition is that this will be a significant tool in preventing unnecessary and incorrect antibiotic prescriptions for the treatment of UTIs, and assist in the slowing of the impact of AMR. If you are interested in hearing more about our revolutionary UTI diagnostic system then please feel free to contact us.
🔬 At yesterday's United Nations General Assembly (UNGA) High-Level Meeting on AMR, world leaders approved a political declaration pledging action to combat this looming global health crisis. The declaration included: 🔴 A commitment to reduce the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030. 🔴 Calls for sustainable national financing and US$100 million in catalytic funding, to help achieve a target of at least 60% of countries having funded national action plans on AMR by 2030. 🔴 An agreement to establish an independent panel for evidence-based action against AMR. The panel, which the EU will help to fund with €2.5 million in 2025, will gather and consolidate data on AMR and provide guidance to policymakers worldwide. We would also like to echo, in particular, the Executive Chair of the Fleming Initiative, Lord Darzi's, comments ahead of the UNGA meeting that by 2030 antibiotic prescriptions should not be provided without a diagnosis that explicitly identifies the underlying cause as bacterial infection. He stated that this will require "unprecedented co-operation, significant investment in diagnostic technologies and a fundamental shift in prescribing practices worldwide." Diagnostics save lives now, and in the future, by preventing unnecessary antibiotic prescriptions, which slows the impact of AMR. In the UK, we must do more to ensure diagnostics are better utilised, especially in routine primary care interactions, to fully play our part in this international fight.